Miguel Nobre Menezes
@mnobremenezes
Followers
352
Following
4K
Statuses
542
MD, Cardiologist, Interventional Cardiologist, Cardio-Oncology
Lisboa, Portugal
Joined May 2018
RT @jsmarques_MD: #LeaveNothingBehind at @ulssanta_maria Cath Lab! 🚀 CHIP PCI & DCB day: 🩺 RCA: #Rotashock + 3 DCBs for severe calcificati…
0
2
0
Thank you so much @mmamas1973! It was an absolute pleasure and honor! Very happy, proud and grateful to all @fjpinto1960
Congratulations for a superb defence of the phd thesis by @mnobremenezes , with photos with the examination committee and naturally a selfie with candidate and supervisor @fjpinto1960 Its a real pleasure to examine high calibre work
3
2
30
1
0
1
Thank you so much @mmamas1973! It was such an honour and a pleasure! Very happy and very proud @fjpinto1960
Congratulations for a superb defence of the phd thesis by @mnobremenezes , with photos with the examination committee and naturally a selfie with candidate and supervisor @fjpinto1960 Its a real pleasure to examine high calibre work
1
2
19
RT @QuinaCatarina: “Unveiling the power of DCB’S within the PCI Toolbox” - It was a great discussion at #APIC VĂctor Alfonso JimĂ©nez DĂaz…
0
2
0
@DFCapodanno Not good news. Where will this leave QFR? Perhaps a negative QFR and stop the procedure, and positive QFR -> confirm with FFR and proceed accordingly?
0
0
2
@Hragy @mmamas1973 @ShariqShamimMD @mirvatalasnag @DFCapodanno @DrMarthaGulati True, but seems an unlikely problem given their age. More likely that waiting till limiting symptoms is more detrimental to patients. I find that active patients often manifest symptoms and get treated earlier, and have seen no issues with them at all.
1
0
0
@kaulcsmc @DFCapodanno Agree. But the MI finding is very relevant. Not sure the same applies to this AS trial, but I have yet do dissect it.
0
0
0
@kaulcsmc @DFCapodanno Plus this. And we know a spontaneous MI is more dangerous than a periprocedural one. The ISCHEMIA trial itself has nice data on this. This is FAME 2 at 5 years.
0
0
0
@kaulcsmc @DFCapodanno FAME 2 was significantly different for spontaneous MI, at both 2 and 5 years. Not a soft endpoint
2
0
0
RT @camalees: Em 24 horas este é o resultado da angariação de fundos para o Tiago. No dia 31.10 a totalidade da verba angariada será trans…
0
82
0
@ahmad_70x @drjohnm @mmamas1973 @Hragy @mirvatalasnag @GreggWStone That’s why I believe the specified proximal LAD based on CASS. But clearly they’re trying to be neither entirely conservative nor invasive in the text. Still, how do you usually actually handle a severe proximal LAD in clinical practice amenable to revasc?
0
0
2
@mmamas1973 @thetimes @martinmckee @TYoungstein @djnicholl @DrAsifQasim @parthaskar @trishgreenhalgh @doctor_oxford @drmattuk @nolanjimradial @ShrillaB @DrOKaneAgain @kidneydoc101 More than pausing, complete reversal and back to proper Medicine fit for purpose. Just train proper Doctors!
0
1
13
@mmamas1973 @JungMinAhn5 Agree - so sorry I couldn’t attend this year. Both trials facilitate everyday issues: from “clearing” patients for ordinary procedures to strengthening a conservative approach in frail patients we’re often very wary of “cathing”. I still need to deeply analyze the latter though
0
0
2
@pomyers @DFCapodanno This is the very opposite of pragmatic. A pragmatist adheres to objective reality rather than overcomplicating or negating the basic and obvious. Risk often differs according to sex. Are you unaware of a patient’s sex e.g male or female when practising? Truly harrowing
0
0
0
@DFCapodanno Also, the very fact that prolific scientific colleagues qualify the decision so blandly or not at all speaks volumes. As does the choice of target, as CHA2DS2–VASc is so famous, therefore everyone talks about this. Unsurprisingly, reactions in private are rather less lukewarm.
0
0
3